<!-- html table generated in R 3.3.1 by xtable 1.8-2 package -->
<!-- Thu Mar 29 18:12:19 2018 -->
<table border=1>
<tr> <th>  </th> <th> GOBPID </th> <th> Pvalue </th> <th> OddsRatio </th> <th> ExpCount </th> <th> Count </th> <th> Size </th> <th> Term </th> <th> Genes </th>  </tr>
  <tr> <td> 1 </td> <td align="center"> GO:0007283 </td> <td align="right"> 2.1e-18 </td> <td align="right"> 5.13 </td> <td align="right"> 12.13 </td> <td align="right">  51 </td> <td align="right"> 437 </td> <td> spermatogenesis </td> <td> BRCA2, BRDT, CCIN, CYLC1, CYLC2, DMRT1, GLI1, PRKACG, SYCP1, TCP11, TNP2, FKBP6, SOX30, ADAM29, SPO11, CABYR, VCX, DUSP13, MOV10L1, DDX4, RNF17, TSPY2, BOLL, CATSPERB, SHCBP1L, SPATA16, TSSK1B, TXNDC2, CABS1, GTSF1, ZPBP2, SPATA32, CALR3, ADAD1, ASZ1, SUN5, CNBD2, RNF151, CCDC155, TBC1D21, FAM9A, FAM9B, SPATA19, TXNDC8, CATSPERD, SPEM1, CATSPER4, SPATA31D3, SPATA31D1, TEX19, SPATA31A1 </td> </tr>
  <tr> <td> 2 </td> <td align="center"> GO:0044703 </td> <td align="right"> 3.7e-16 </td> <td align="right"> 3.60 </td> <td align="right"> 22.34 </td> <td align="right">  67 </td> <td align="right"> 808 </td> <td> multi-organism reproductive process </td> <td> BRCA2, BRDT, CCIN, CYLC1, CYLC2, CYP1A1, DMRT1, FOXC1, ADAM2, GLI1, INHBB, NPPA, PRKACG, SEMG1, SPINK2, SYCP1, TCP11, SCGB1A1, VDR, FKBP6, AKAP4, AKAP3, ZPBP, SOX30, ADAM30, ADAM29, SPO11, CABYR, VCX, DUSP13, MOV10L1, DDX4, RNF17, TSPY2, BOLL, LIN28A, CATSPERB, SHCBP1L, SPATA16, TSSK1B, TXNDC2, CABS1, GTSF1, SPACA7, ZPBP2, SPATA32, SPACA3, CALR3, ADAD1, ASZ1, SUN5, CNBD2, RNF151, CCDC155, TBC1D21, FAM9A, FAM9B, SPATA19, TXNDC8, CATSPERD, SPEM1, CATSPER4, SPATA31D3, SPATA31D1, TEX19, OOEP, SPATA31A1 </td> </tr>
  <tr> <td> 3 </td> <td align="center"> GO:0007276 </td> <td align="right"> 1.7e-14 </td> <td align="right"> 4.07 </td> <td align="right"> 14.54 </td> <td align="right">  50 </td> <td align="right"> 528 </td> <td> gamete generation </td> <td> BRCA2, BRDT, CCIN, CYLC1, CYLC2, DMRT1, FOXC1, GLI1, INHBB, PRKACG, SYCP1, TCP11, TNP2, SOX30, ADAM29, SPO11, CABYR, VCX, DUSP13, RNF17, TSPY2, BOLL, LIN28A, CATSPERB, SHCBP1L, SPATA16, TSSK1B, TXNDC2, CABS1, GTSF1, ZPBP2, SPATA32, CALR3, ADAD1, SUN5, CNBD2, RNF151, CCDC155, TBC1D21, FAM9A, FAM9B, SPATA19, TXNDC8, CATSPERD, SPEM1, CATSPER4, SPATA31D3, SPATA31D1, TEX19, SPATA31A1 </td> </tr>
  <tr> <td> 4 </td> <td align="center"> GO:0032504 </td> <td align="right"> 4.7e-10 </td> <td align="right"> 3.57 </td> <td align="right"> 12.16 </td> <td align="right">  38 </td> <td align="right"> 455 </td> <td> multicellular organism reproduction </td> <td> BRDT, CCIN, CYLC1, CYLC2, CYP1A1, GLI1, INHA, SMCP, PRKACG, SEMG1, TCP11, TNP2, VDR, FKBP6, SOX30, ADAM29, VCX, DUSP13, DDX4, TSPY2, BOLL, SHCBP1L, SPATA16, TXNDC2, CABS1, GTSF1, SPATA32, CALR3, ASZ1, SUN5, CNBD2, RNF151, TBC1D21, SPATA19, SPATA31D3, SPATA31D1, TEX19, SPATA31A1 </td> </tr>
  <tr> <td> 5 </td> <td align="center"> GO:0042693 </td> <td align="right"> 2.8e-06 </td> <td align="right"> 21.30 </td> <td align="right"> 0.44 </td> <td align="right">   6 </td> <td align="right">  16 </td> <td> muscle cell fate commitment </td> <td> MYF5, MYF6, MYOD1, MYOG, TBX1, TBX3 </td> </tr>
  <tr> <td> 6 </td> <td align="center"> GO:0007126 </td> <td align="right"> 1.1e-05 </td> <td align="right"> 3.98 </td> <td align="right"> 4.47 </td> <td align="right">  16 </td> <td align="right"> 161 </td> <td> meiotic nuclear division </td> <td> BRCA2, BRDT, DMRT1, SYCP1, FKBP6, SPO11, RAD54B, DUSP13, MOV10L1, DDX4, PRDM9, BOLL, ASZ1, CCDC155, TERB1, FBXO43 </td> </tr>
  <tr> <td> 7 </td> <td align="center"> GO:0009566 </td> <td align="right"> 1.1e-05 </td> <td align="right"> 4.19 </td> <td align="right"> 4.00 </td> <td align="right">  15 </td> <td align="right"> 144 </td> <td> fertilization </td> <td> ADAM2, SMCP, SPINK2, TNP2, AKAP4, AKAP3, ZPBP, ADAM30, CATSPERB, SPACA7, ZPBP2, SPACA3, CATSPERD, CATSPER4, OOEP </td> </tr>
  <tr> <td> 8 </td> <td align="center"> GO:0034587 </td> <td align="right"> 3.8e-05 </td> <td align="right"> 17.71 </td> <td align="right"> 0.42 </td> <td align="right">   5 </td> <td align="right">  15 </td> <td> piRNA metabolic process </td> <td> FKBP6, MOV10L1, DDX4, ASZ1, EXD1 </td> </tr>
  <tr> <td> 9 </td> <td align="center"> GO:0022412 </td> <td align="right"> 4.1e-05 </td> <td align="right"> 3.23 </td> <td align="right"> 6.09 </td> <td align="right">  18 </td> <td align="right"> 221 </td> <td> cellular process involved in reproduction in multicellular organism </td> <td> BRCA2, DMRT1, FOXC1, ADAM2, INHBB, SYCP1, SPO11, MOV10L1, RNF17, LIN28A, TSSK1B, ZPBP2, ADAD1, CCDC155, FAM9A, FAM9B, TXNDC8, SPEM1 </td> </tr>
  <tr> <td> 10 </td> <td align="center"> GO:0001501 </td> <td align="right"> 4.3e-05 </td> <td align="right"> 2.43 </td> <td align="right"> 12.91 </td> <td align="right">  29 </td> <td align="right"> 465 </td> <td> skeletal system development </td> <td> COMP, EN1, FGF4, FOXC1, FOXC2, GJA5, HOXC5, HOXC6, HOXC8, HOXC9, HOXC10, HOXC11, INHA, MATN3, MYF5, PITX2, PRRX1, SIX1, SRD5A2, TBX1, TBX15, TBX3, VDR, HMGA2, TNFSF11, MTHFD1L, TRIM45, OSR1, MUSTN1 </td> </tr>
  <tr> <td> 11 </td> <td align="center"> GO:0007389 </td> <td align="right"> 4.7e-05 </td> <td align="right"> 2.56 </td> <td align="right"> 11.01 </td> <td align="right">  26 </td> <td align="right"> 399 </td> <td> pattern specification process </td> <td> ASCL1, EGR2, EN1, FOXC1, FOXC2, GLI1, HOXC5, HOXC6, HOXC8, HOXC9, HOXC10, HOXC11, MYF5, MYF6, PITX2, SIX1, TBX1, TBX3, NKX2-1, WNT2, LHX3, TBX18, VAX2, DMRT3, FOXN4, OOEP </td> </tr>
  <tr> <td> 12 </td> <td align="center"> GO:1901741 </td> <td align="right"> 5.5e-05 </td> <td align="right"> 16.10 </td> <td align="right"> 0.44 </td> <td align="right">   5 </td> <td align="right">  16 </td> <td> positive regulation of myoblast fusion </td> <td> MYF5, MYF6, MYOD1, MYOG, SCGB3A1 </td> </tr>
  <tr> <td> 13 </td> <td align="center"> GO:0009952 </td> <td align="right"> 6.8e-05 </td> <td align="right"> 3.37 </td> <td align="right"> 5.19 </td> <td align="right">  16 </td> <td align="right"> 187 </td> <td> anterior/posterior pattern specification </td> <td> EN1, FOXC1, FOXC2, HOXC5, HOXC6, HOXC8, HOXC9, HOXC10, HOXC11, MYF5, MYF6, TBX1, TBX3, WNT2, TBX18, OSR1 </td> </tr>
  <tr> <td> 14 </td> <td align="center"> GO:0019731 </td> <td align="right"> 0.0001 </td> <td align="right"> 7.54 </td> <td align="right"> 1.11 </td> <td align="right">   7 </td> <td align="right">  40 </td> <td> antibacterial humoral response </td> <td> KLK3, DEFA5, DEFA6, DMBT1, SEMG1, SEMG2, BPIFA1 </td> </tr>
  <tr> <td> 15 </td> <td align="center"> GO:0048704 </td> <td align="right"> 0.00018 </td> <td align="right"> 4.52 </td> <td align="right"> 2.47 </td> <td align="right">  10 </td> <td align="right">  89 </td> <td> embryonic skeletal system morphogenesis </td> <td> FOXC2, HOXC9, HOXC11, MYF5, PRRX1, SIX1, TBX1, TBX15, MTHFD1L, OSR1 </td> </tr>
  <tr> <td> 16 </td> <td align="center"> GO:0060142 </td> <td align="right"> 0.00029 </td> <td align="right"> 10.41 </td> <td align="right"> 0.61 </td> <td align="right">   5 </td> <td align="right">  22 </td> <td> regulation of syncytium formation by plasma membrane fusion </td> <td> MYF5, MYF6, MYOD1, MYOG, SCGB3A1 </td> </tr>
  <tr> <td> 17 </td> <td align="center"> GO:0000003 </td> <td align="right"> 0.00031 </td> <td align="right"> 2.81 </td> <td align="right"> 6.51 </td> <td align="right">  17 </td> <td align="right"> 269 </td> <td> reproduction </td> <td> NPPA, SPINK2, SCGB1A1, MMP23B, AKAP4, AKAP3, ZPBP, ADAM30, RAD54B, PRDM9, SPACA7, SPACA3, EXD1, REC114, TERB1, FBXO43, OOEP </td> </tr>
  <tr> <td> 18 </td> <td align="center"> GO:0009617 </td> <td align="right"> 0.00041 </td> <td align="right"> 2.20 </td> <td align="right"> 12.61 </td> <td align="right">  26 </td> <td align="right"> 454 </td> <td> response to bacterium </td> <td> KLK3, CD80, CYP1A1, DEFA5, DEFA6, DMBT1, HP, IL13, LBP, LPO, PPBP, CXCL5, SEMG1, SEMG2, STAR, STATH, SCGB1A1, BPIFA1, EPPIN, LYZL6, AICDA, LYZL1, LYZL2, SPACA3, DEFB119, DEFB123 </td> </tr>
  <tr> <td> 19 </td> <td align="center"> GO:0007286 </td> <td align="right"> 0.00046 </td> <td align="right"> 3.95 </td> <td align="right"> 2.78 </td> <td align="right">  10 </td> <td align="right"> 101 </td> <td> spermatid development </td> <td> SYCP1, SPO11, RNF17, TSSK1B, ZPBP2, ADAD1, FAM9A, FAM9B, TXNDC8, SPEM1 </td> </tr>
  <tr> <td> 20 </td> <td align="center"> GO:0019748 </td> <td align="right"> 0.00049 </td> <td align="right"> 5.65 </td> <td align="right"> 1.42 </td> <td align="right">   7 </td> <td align="right">  51 </td> <td> secondary metabolic process </td> <td> CYP1A1, CYP1B1, CYP11B1, CYP11B2, AKR1C1, AKR1C2, STAR </td> </tr>
  <tr> <td> 21 </td> <td align="center"> GO:0060415 </td> <td align="right"> 0.00063 </td> <td align="right"> 4.66 </td> <td align="right"> 1.92 </td> <td align="right">   8 </td> <td align="right">  69 </td> <td> muscle tissue morphogenesis </td> <td> FOXC1, FOXC2, MYF5, MYF6, PITX2, TBX1, TNNI1, WNT2 </td> </tr>
  <tr> <td> 22 </td> <td align="center"> GO:0030317 </td> <td align="right"> 0.00067 </td> <td align="right"> 5.33 </td> <td align="right"> 1.49 </td> <td align="right">   7 </td> <td align="right">  54 </td> <td> flagellated sperm motility </td> <td> SMCP, PGK2, AKAP4, DDX4, CATSPERD, SPEM1, CATSPER4 </td> </tr>
  <tr> <td> 23 </td> <td align="center"> GO:0035094 </td> <td align="right"> 0.00076 </td> <td align="right"> 6.25 </td> <td align="right"> 1.11 </td> <td align="right">   6 </td> <td align="right">  40 </td> <td> response to nicotine </td> <td> CHRNA1, CHRND, CHRNE, CHRNG, IL13, STAR </td> </tr>
  <tr> <td> 24 </td> <td align="center"> GO:0048665 </td> <td align="right"> 0.00079 </td> <td align="right"> 8.04 </td> <td align="right"> 0.75 </td> <td align="right">   5 </td> <td align="right">  27 </td> <td> neuron fate specification </td> <td> ASCL1, HOXC10, SIX1, LHX3, DMRT3 </td> </tr>
  <tr> <td> 25 </td> <td align="center"> GO:0060537 </td> <td align="right"> 0.00091 </td> <td align="right"> 2.33 </td> <td align="right"> 9.14 </td> <td align="right">  20 </td> <td align="right"> 329 </td> <td> muscle tissue development </td> <td> CHRNA1, CHRND, EGR2, FOXC1, FOXC2, GJA5, MYF5, MYF6, MYOD1, MYOG, NPPA, PITX2, SGCG, SIX1, TBX1, TBX3, TNNI1, WNT2, NOX4, OSR1 </td> </tr>
  <tr> <td> 26 </td> <td align="center"> GO:1904888 </td> <td align="right"> 0.00097 </td> <td align="right"> 4.97 </td> <td align="right"> 1.58 </td> <td align="right">   7 </td> <td align="right">  57 </td> <td> cranial skeletal system development </td> <td> FGF4, FOXC2, PRRX1, SIX1, TBX1, TBX15, MTHFD1L </td> </tr>
  <tr> <td> 27 </td> <td align="center"> GO:0061458 </td> <td align="right"> 0.0012 </td> <td align="right"> 2.18 </td> <td align="right"> 10.69 </td> <td align="right">  22 </td> <td align="right"> 385 </td> <td> reproductive system development </td> <td> BRCA2, CYP19A1, DMRT1, FOXC1, ID4, INHA, INHBB, PITX2, PRKACG, SRD5A2, SRY, STAR, TBX3, NKX2-1, VDR, WNT2, LHX3, PLK4, SPO11, ANKRD7, TSPY2, OSR1 </td> </tr>
  <tr> <td> 28 </td> <td align="center"> GO:0006949 </td> <td align="right"> 0.0013 </td> <td align="right"> 5.59 </td> <td align="right"> 1.22 </td> <td align="right">   6 </td> <td align="right">  44 </td> <td> syncytium formation </td> <td> MYF5, MYF6, MYOD1, MYOG, PITX2, SCGB3A1 </td> </tr>
  <tr> <td> 29 </td> <td align="center"> GO:0035914 </td> <td align="right"> 0.0016 </td> <td align="right"> 4.52 </td> <td align="right"> 1.72 </td> <td align="right">   7 </td> <td align="right">  62 </td> <td> skeletal muscle cell differentiation </td> <td> EGR2, MYF5, MYF6, MYOD1, MYOG, SIX1, TBX1 </td> </tr>
  <tr> <td> 30 </td> <td align="center"> GO:0009954 </td> <td align="right"> 0.0017 </td> <td align="right"> 6.55 </td> <td align="right"> 0.89 </td> <td align="right">   5 </td> <td align="right">  32 </td> <td> proximal/distal pattern formation </td> <td> EN1, GLI1, HOXC10, HOXC11, OSR1 </td> </tr>
  <tr> <td> 31 </td> <td align="center"> GO:0048641 </td> <td align="right"> 0.0018 </td> <td align="right"> 5.18 </td> <td align="right"> 1.31 </td> <td align="right">   6 </td> <td align="right">  47 </td> <td> regulation of skeletal muscle tissue development </td> <td> MYF5, MYF6, MYOD1, MYOG, SIX1, TBX1 </td> </tr>
  <tr> <td> 32 </td> <td align="center"> GO:0009410 </td> <td align="right"> 0.002 </td> <td align="right"> 3.48 </td> <td align="right"> 2.80 </td> <td align="right">   9 </td> <td align="right"> 101 </td> <td> response to xenobiotic stimulus </td> <td> CYP1A1, CYP1B1, CYP3A7, AKR1C1, DPEP1, LPO, STAR, SCGB1A1, AHRR </td> </tr>
  <tr> <td> 33 </td> <td align="center"> GO:0048736 </td> <td align="right"> 0.002 </td> <td align="right"> 2.84 </td> <td align="right"> 4.53 </td> <td align="right">  12 </td> <td align="right"> 163 </td> <td> appendage development </td> <td> COMP, EN1, FGF4, GJA5, HOXC10, HOXC11, PITX2, PRRX1, TBX3, SALL4, SMOC1, OSR1 </td> </tr>
  <tr> <td> 34 </td> <td align="center"> GO:0034754 </td> <td align="right"> 0.0021 </td> <td align="right"> 3.44 </td> <td align="right"> 2.83 </td> <td align="right">   9 </td> <td align="right"> 102 </td> <td> cellular hormone metabolic process </td> <td> CYP1B1, CYP11B1, CYP11B2, CYP17A1, CYP19A1, AKR1C1, AKR1C2, SRD5A2, STAR </td> </tr>
  <tr> <td> 35 </td> <td align="center"> GO:0035113 </td> <td align="right"> 0.0021 </td> <td align="right"> 3.18 </td> <td align="right"> 3.39 </td> <td align="right">  10 </td> <td align="right"> 122 </td> <td> embryonic appendage morphogenesis </td> <td> EN1, FGF4, GJA5, HOXC10, HOXC11, PITX2, PRRX1, TBX3, SALL4, OSR1 </td> </tr>
  <tr> <td> 36 </td> <td align="center"> GO:0003006 </td> <td align="right"> 0.0022 </td> <td align="right"> 2.25 </td> <td align="right"> 8.46 </td> <td align="right">  18 </td> <td align="right"> 317 </td> <td> developmental process involved in reproduction </td> <td> CYP19A1, ID4, SYCP1, VDR, WNT2, LHX3, PLK4, MOV10L1, RNF17, LIN28A, TSSK1B, ZPBP2, ADAD1, CCDC155, FAM9A, FAM9B, TXNDC8, SPEM1 </td> </tr>
  <tr> <td> 37 </td> <td align="center"> GO:0010830 </td> <td align="right"> 0.0023 </td> <td align="right"> 4.94 </td> <td align="right"> 1.36 </td> <td align="right">   6 </td> <td align="right">  49 </td> <td> regulation of myotube differentiation </td> <td> MYF5, MYF6, MYOD1, MYOG, TBX1, SCGB3A1 </td> </tr>
  <tr> <td> 38 </td> <td align="center"> GO:0003151 </td> <td align="right"> 0.0023 </td> <td align="right"> 4.21 </td> <td align="right"> 1.83 </td> <td align="right">   7 </td> <td align="right">  66 </td> <td> outflow tract morphogenesis </td> <td> FOXC1, FOXC2, GJA5, PITX2, SIX1, TBX1, TBX3 </td> </tr>
  <tr> <td> 39 </td> <td align="center"> GO:0046661 </td> <td align="right"> 0.0027 </td> <td align="right"> 2.88 </td> <td align="right"> 4.08 </td> <td align="right">  11 </td> <td align="right"> 147 </td> <td> male sex differentiation </td> <td> DMRT1, INHA, PITX2, PRKACG, SRD5A2, SRY, STAR, TBX3, NKX2-1, ANKRD7, DMRT3 </td> </tr>
  <tr> <td> 40 </td> <td align="center"> GO:0051155 </td> <td align="right"> 0.0028 </td> <td align="right"> 4.72 </td> <td align="right"> 1.42 </td> <td align="right">   6 </td> <td align="right">  51 </td> <td> positive regulation of striated muscle cell differentiation </td> <td> MYF5, MYF6, MYOD1, MYOG, TBX1, SCGB3A1 </td> </tr>
  <tr> <td> 41 </td> <td align="center"> GO:0048568 </td> <td align="right"> 0.0029 </td> <td align="right"> 2.05 </td> <td align="right"> 10.80 </td> <td align="right">  21 </td> <td align="right"> 389 </td> <td> embryonic organ development </td> <td> EN1, FOXC1, FOXC2, GJA5, GLI1, HOXC9, HOXC11, MYF5, PITX2, PRRX1, SIX1, TBX1, TBX15, TBX3, WNT2, PAX8, PLK4, VAX2, MTHFD1L, FOXN4, OSR1 </td> </tr>
  <tr> <td> 42 </td> <td align="center"> GO:0055002 </td> <td align="right"> 0.0032 </td> <td align="right"> 2.99 </td> <td align="right"> 3.58 </td> <td align="right">  10 </td> <td align="right"> 129 </td> <td> striated muscle cell development </td> <td> MYF5, MYF6, MYOD1, MYOG, NPPA, PITX2, TBX3, CACNA2D2, MYOZ1, MYOZ3 </td> </tr>
  <tr> <td> 43 </td> <td align="center"> GO:0048844 </td> <td align="right"> 0.0037 </td> <td align="right"> 4.43 </td> <td align="right"> 1.50 </td> <td align="right">   6 </td> <td align="right">  54 </td> <td> artery morphogenesis </td> <td> FOXC1, FOXC2, GJA5, PRRX1, SIX1, TBX1 </td> </tr>
  <tr> <td> 44 </td> <td align="center"> GO:0009953 </td> <td align="right"> 0.0038 </td> <td align="right"> 3.42 </td> <td align="right"> 2.53 </td> <td align="right">   8 </td> <td align="right">  91 </td> <td> dorsal/ventral pattern formation </td> <td> ASCL1, EN1, GLI1, NKX2-1, LHX3, VAX2, DMRT3, FOXN4 </td> </tr>
  <tr> <td> 45 </td> <td align="center"> GO:0030154 </td> <td align="right"> 0.0039 </td> <td align="right"> 1.37 </td> <td align="right"> 87.26 </td> <td align="right"> 110 </td> <td align="right"> 3213 </td> <td> cell differentiation </td> <td> BRCA2, BRDT, CCIN, CD80, CETP, CNTF, CTH, CYLC1, CYLC2, CYP1A1, AKR1C1, AKR1C2, DFNA5, DMBT1, DMRT1, EN1, ETV4, FGF4, FOXC1, FOXD1, FOXC2, GLI1, HOXC8, ID4, IL13, INHA, INHBB, NEFH, NPPA, REG3A, PITX2, PRRX1, POU3F2, PTPRD, SGCG, SRD5A2, SRY, STAR, SYCP1, TBX3, TCP11, NKX2-1, TNP2, TPH1, VDR, WNT2, LRP8, PAX8, HMGA2, SOAT2, FKBP6, TNFSF11, CACNA2D2, MRC2, PLK4, CCR9, GADD45G, PRAME, SPO11, BAMBI, VAX2, CABYR, NOX4, SPTBN5, MOV10L1, DDX4, ULK4, MCOLN3, RNF17, AICDA, MYOZ1, EDA2R, SMOC1, TNMD, TSPY2, BOLL, LIN28A, CATSPERB, HDAC11, ACTL8, SHCBP1L, SPATA16, TSSK1B, TXNDC2, MYOZ3, SCGB3A1, PRDM6, GTSF1, ZPBP2, CALR3, OSR1, ADAD1, ASZ1, RNF151, CCDC155, LELP1, TBC1D21, FAM9A, FAM9B, SPATA19, TXNDC8, CATSPERD, IGSF10, SPEM1, CATSPER4, MUSTN1, SPATA31D3, SPATA31D1, TEX19, SPATA31A1 </td> </tr>
  <tr> <td> 46 </td> <td align="center"> GO:0016125 </td> <td align="right"> 0.0042 </td> <td align="right"> 2.87 </td> <td align="right"> 3.72 </td> <td align="right">  10 </td> <td align="right"> 134 </td> <td> sterol metabolic process </td> <td> ACADL, CETP, CYP1B1, CYP11B1, CYP11B2, CYP17A1, CYP19A1, STAR, CUBN, SOAT2 </td> </tr>
  <tr> <td> 47 </td> <td align="center"> GO:0042475 </td> <td align="right"> 0.0044 </td> <td align="right"> 3.70 </td> <td align="right"> 2.05 </td> <td align="right">   7 </td> <td align="right">  74 </td> <td> odontogenesis of dentin-containing tooth </td> <td> FGF4, FOXC1, PITX2, TBX1, KLK4, DMRT3, AMTN </td> </tr>
  <tr> <td> 48 </td> <td align="center"> GO:0021983 </td> <td align="right"> 0.0048 </td> <td align="right"> 5.05 </td> <td align="right"> 1.11 </td> <td align="right">   5 </td> <td align="right">  40 </td> <td> pituitary gland development </td> <td> GLI1, PITX2, POU3F2, NKX2-1, LHX3 </td> </tr>
  <tr> <td> 49 </td> <td align="center"> GO:0061061 </td> <td align="right"> 0.0054 </td> <td align="right"> 1.80 </td> <td align="right"> 15.16 </td> <td align="right">  26 </td> <td align="right"> 546 </td> <td> muscle structure development </td> <td> CHRNA1, CHRND, CNTF, CTH, EGR2, FOXC1, FOXC2, MYF5, MYF6, MYOD1, MYOG, NEB, NPPA, PITX2, SGCG, SIX1, TBX1, TBX3, TNNI1, WNT2, CACNA2D2, NOX4, MYOZ1, MYOZ3, SCGB3A1, PRDM6 </td> </tr>
  <tr> <td> 50 </td> <td align="center"> GO:0021517 </td> <td align="right"> 0.0059 </td> <td align="right"> 4.78 </td> <td align="right"> 1.17 </td> <td align="right">   5 </td> <td align="right">  42 </td> <td> ventral spinal cord development </td> <td> ASCL1, HOXC10, LHX3, DMRT3, FOXN4 </td> </tr>
  <tr> <td> 51 </td> <td align="center"> GO:0035108 </td> <td align="right"> 0.006 </td> <td align="right"> 2.71 </td> <td align="right"> 3.92 </td> <td align="right">  10 </td> <td align="right"> 141 </td> <td> limb morphogenesis </td> <td> EN1, FGF4, GJA5, HOXC10, HOXC11, PITX2, PRRX1, TBX3, SALL4, OSR1 </td> </tr>
  <tr> <td> 52 </td> <td align="center"> GO:0046660 </td> <td align="right"> 0.0063 </td> <td align="right"> 3.12 </td> <td align="right"> 2.75 </td> <td align="right">   8 </td> <td align="right">  99 </td> <td> female sex differentiation </td> <td> BRCA2, FOXC1, INHA, INHBB, PITX2, SRD5A2, TBX3, SPO11 </td> </tr>
  <tr> <td> 53 </td> <td align="center"> GO:0042446 </td> <td align="right"> 0.0068 </td> <td align="right"> 3.86 </td> <td align="right"> 1.69 </td> <td align="right">   6 </td> <td align="right">  61 </td> <td> hormone biosynthetic process </td> <td> CYP11B1, CYP11B2, CYP17A1, CYP19A1, SRD5A2, STAR </td> </tr>
  <tr> <td> 54 </td> <td align="center"> GO:0045844 </td> <td align="right"> 0.0068 </td> <td align="right"> 3.86 </td> <td align="right"> 1.69 </td> <td align="right">   6 </td> <td align="right">  61 </td> <td> positive regulation of striated muscle tissue development </td> <td> MYF5, MYF6, MYOD1, MYOG, TBX1, WNT2 </td> </tr>
  <tr> <td> 55 </td> <td align="center"> GO:0008406 </td> <td align="right"> 0.0069 </td> <td align="right"> 3.85 </td> <td align="right"> 1.70 </td> <td align="right">   6 </td> <td align="right">  62 </td> <td> gonad development </td> <td> BRCA2, FOXC1, INHBB, SPO11, TSPY2, OSR1 </td> </tr>
  <tr> <td> 56 </td> <td align="center"> GO:0048754 </td> <td align="right"> 0.0076 </td> <td align="right"> 2.61 </td> <td align="right"> 4.05 </td> <td align="right">  10 </td> <td align="right"> 146 </td> <td> branching morphogenesis of an epithelial tube </td> <td> ETV4, FOXD1, FOXC2, PITX2, SIX1, TBX3, NKX2-1, VDR, WNT2, PAX8 </td> </tr>
  <tr> <td> 57 </td> <td align="center"> GO:0021515 </td> <td align="right"> 0.0079 </td> <td align="right"> 4.42 </td> <td align="right"> 1.25 </td> <td align="right">   5 </td> <td align="right">  45 </td> <td> cell differentiation in spinal cord </td> <td> ASCL1, HOXC10, LHX3, DMRT3, FOXN4 </td> </tr>
  <tr> <td> 58 </td> <td align="center"> GO:0061180 </td> <td align="right"> 0.0079 </td> <td align="right"> 3.72 </td> <td align="right"> 1.75 </td> <td align="right">   6 </td> <td align="right">  63 </td> <td> mammary gland epithelium development </td> <td> BRCA2, ETV4, TBX3, VDR, WNT2, TNFSF11 </td> </tr>
  <tr> <td> 59 </td> <td align="center"> GO:0050881 </td> <td align="right"> 0.0087 </td> <td align="right"> 4.31 </td> <td align="right"> 1.28 </td> <td align="right">   5 </td> <td align="right">  46 </td> <td> musculoskeletal movement </td> <td> ASCL1, ATP2A1, CHRNA1, CHRND, TNNI1 </td> </tr>
  <tr> <td> 60 </td> <td align="center"> GO:0008584 </td> <td align="right"> 0.009 </td> <td align="right"> 2.71 </td> <td align="right"> 3.53 </td> <td align="right">   9 </td> <td align="right"> 127 </td> <td> male gonad development </td> <td> DMRT1, INHA, PITX2, PRKACG, SRD5A2, SRY, STAR, NKX2-1, ANKRD7 </td> </tr>
  <tr> <td> 61 </td> <td align="center"> GO:0050829 </td> <td align="right"> 0.0095 </td> <td align="right"> 4.21 </td> <td align="right"> 1.31 </td> <td align="right">   5 </td> <td align="right">  47 </td> <td> defense response to Gram-negative bacterium </td> <td> LBP, LYZL6, LYZL1, LYZL2, SPACA3 </td> </tr>
   </table>
